CRRT (Continuous Renal Replacement Therapy) - Revision history

Christopher.Deeble at 21:48, 4 May 2024

2024-05-04T21:48:26Z

← Older revision		Revision as of 14:48, 4 May 2024
Line 12:		Line 12:
	Provides renal support to patients. Usually veno-venous, but arterio-venous exists too (not covered here).		Provides renal support to patients. Usually veno-venous, but arterio-venous exists too (not covered here).

	== ~~System properties and mechanisms~~ ==		== Properties ==
	'''Solute removal mechanisms:'''		'''Solute removal mechanisms:'''

Christopher.Deeble at 21:48, 4 May 2024

2024-05-04T21:48:04Z

← Older revision		Revision as of 14:48, 4 May 2024
Line 12:		Line 12:
	Provides renal support to patients. Usually veno-venous, but arterio-venous exists too (not covered here).		Provides renal support to patients. Usually veno-venous, but arterio-venous exists too (not covered here).

	== ~~Mechanisms~~ ==		== System properties and mechanisms ==
	'''Solute removal mechanisms:'''		'''Solute removal mechanisms:'''

Line 32:		Line 32:
	* Membrane sieving coefficient: ratio of specific solute concentration in ultrafiltrate (only removed by convection) divided by mean plasma concentration in filter		* Membrane sieving coefficient: ratio of specific solute concentration in ultrafiltrate (only removed by convection) divided by mean plasma concentration in filter
	* Cutoff: molecular weight of the smallest solute retained by the membrane		* Cutoff: molecular weight of the smallest solute retained by the membrane
			'''Fluids:'''

			* Can alter pre/post filter replacement fluid compositions to adjust final electrolyte concentrations in blood

	== Types of CRRT (see figure 1 for diagrams) ==		== Types of CRRT (see figure 1 for diagrams) ==
Line 51:		Line 54:
	=== Indications ===		=== Indications ===
	Renal replacement for patients with cardiovascular/hemodynamic instability, acute brain injury, cerebral edema, or raised intracranial pressure (for slow electrolyte correction).		Renal replacement for patients with cardiovascular/hemodynamic instability, acute brain injury, cerebral edema, or raised intracranial pressure (for slow electrolyte correction).

			Can be used during liver transplant surgery for help with electrolyte management, acid-base status, and fluid balance.

	=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===		=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===
Line 70:		Line 75:
	## catheter tip location: SVC/RA		## catheter tip location: SVC/RA
	## 14-17 cm from right subclavian, 17 cm from left subclavian		## 14-17 cm from right subclavian, 17 cm from left subclavian


	'''Anticoagulation:'''		'''Anticoagulation:'''
Line 104:		Line 108:

	Cronin B, O'Brien EO. Intraoperative Renal Replacement Therapy: Practical Information for Anesthesiologists. J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2656-2668. doi: 10.1053/j.jvca.2021.10.002. Epub 2021 Oct 8. PMID: 34750060.		Cronin B, O'Brien EO. Intraoperative Renal Replacement Therapy: Practical Information for Anesthesiologists. J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2656-2668. doi: 10.1053/j.jvca.2021.10.002. Epub 2021 Oct 8. PMID: 34750060.

			Bohorquez H, Koyner JL, Jones CR. Intraoperative Renal Replacement Therapy in Orthotopic Liver Transplantation. Adv Kidney Dis Health. 2023 Jul;30(4):378-386. doi: 10.1053/j.akdh.2023.03.003. PMID: 37657884.
	[[Category:Comorbidities]]		[[Category:Comorbidities]]

Christopher.Deeble at 21:31, 4 May 2024

2024-05-04T21:31:49Z

@@ Line 53: / Line 53: @@
 === Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===
 == Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. -->==
 == References ==

Christopher.Deeble: add

2024-05-04T21:06:29Z

add

← Older revision		Revision as of 14:06, 4 May 2024
Line 12:		Line 12:
	Provides renal support to patients. Usually veno-venous, but arterio-venous exists too (not covered here).		Provides renal support to patients. Usually veno-venous, but arterio-venous exists too (not covered here).

	== Mechanisms ~~and types~~ ==		== Mechanisms ==
	'''Solute removal mechanisms:'''		'''Solute removal mechanisms:'''

	* Diffusion		* Diffusion
	** Accomplished by passive movement of solute across a membrane		** Accomplished by passive movement of solute across a membrane (due to a solute concentration gradient, movement from high to low)
	** Efficient clearance of low-molecular-weight solutes (< 500-1,500 Daltons)		** Efficient clearance of low-molecular-weight solutes (< 500-1,500 Daltons)
	** Clearance decreases with increasing molecular weight of solute		** Clearance decreases with increasing molecular weight of solute
Line 24:		Line 24:
	** Clearance of different size of solute similar until the size of the solute reaches with size of the pores		** Clearance of different size of solute similar until the size of the solute reaches with size of the pores
	** Overall CVVH with higher clearance rate than CVVHD for solutes 1,000 to 20,000 Daltons		** Overall CVVH with higher clearance rate than CVVHD for solutes 1,000 to 20,000 Daltons
			'''Membrane characteristics:'''

			* Geometric: length, mean inner radius, wall thickness, number of pores, number of fibers (determines membrane surface area)
			* Membrane ultrafiltration coefficient: water permeability of filter
			* Filter ultrafiltration coefficient: membrane ultrafiltration coefficient multiplied by membrane surface area
			* Mass transfer area coefficient: overall capacity of membrane to provide diffusive removal of solute
			* Membrane sieving coefficient: ratio of specific solute concentration in ultrafiltrate (only removed by convection) divided by mean plasma concentration in filter
			* Cutoff: molecular weight of the smallest solute retained by the membrane

			== Types of CRRT (see figure 1 for diagrams) ==
	[[File:Img 1.png\|thumb\|Figure 1: Types of CRRT (Recreated based on Tandukar 2019 & Asahi Kasei Medical Co.)]]		[[File:Img 1.png\|thumb\|Figure 1: Types of CRRT (Recreated based on Tandukar 2019 & Asahi Kasei Medical Co.)]]
	'''~~Main types~~ (~~see figure 1 for diagrams~~):'''		'''SCUF (Slow continuous ultrafiltration)'''

	* SCUF (Slow continuous ultrafiltration)		* Convection
	** Convection		* Mainly fluid removal
	** Mainly fluid removal
	* CVVH (Continuous venovenous hemofiltration)		'''CVVH (Continuous venovenous hemofiltration)'''
	** Convection		* Convection
	* CVVHD (Continuous venovenous hemodialysis)		'''CVVHD (Continuous venovenous hemodialysis)'''
	** Diffusion		* Diffusion
	* CVVHDF (Continuous venovenous hemodiafiltration)		'''CVVHDF (Continuous venovenous hemodiafiltration)'''
	** Combination of convection and diffusion		* Combination of convection and diffusion

	== Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> ==		== Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> ==

	=== ~~Preoperative optimization<!-- Describe how this comorbidity may influence preoperative evaluation and optimization of patients. -->~~ ===		=== Indications ===
			Renal replacement for patients with cardiovascular/hemodynamic instability, acute brain injury, cerebral edema, or raised intracranial pressure (for slow electrolyte correction).

	=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===		=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===

	~~=== Postoperative management<!-- Describe how this comorbidity may influence postoperative management. --> ===~~		== Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. -->==

	~~== Related surgical procedures<!-- List and briefly describe any procedures which may be performed specifically to treat this comorbidity or its sequelae. If none, this section may be removed. --> ==~~

	== Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. --> ==

	== Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> ==		== Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> ==

	~~== Diagnosis<!-- Describe how this comorbidity is diagnosed. --> ==~~

	~~== Treatment<!-- Summarize the treatment of this comorbidity. Add subsections as needed. --> ==~~

	~~=== Medication<!-- Describe medications used to manage this comorbidity. --> ===~~

	~~=== Surgery<!-- Describe surgical procedures used to treat this comorbidity. --> ===~~

	~~=== Prognosis<!-- Describe the prognosis of this comorbidity --> ===~~

	== References ==		== References ==
	Tandukar S, Palevsky PM. Continuous Renal Replacement Therapy: Who, When, Why, and How. Chest. 2019 Mar;155(3):626-638. doi: 10.1016/j.chest.2018.09.004. Epub 2018 Sep 25. PMID: 30266628; PMCID: PMC6435902.		Tandukar S, Palevsky PM. Continuous Renal Replacement Therapy: Who, When, Why, and How. Chest. 2019 Mar;155(3):626-638. doi: 10.1016/j.chest.2018.09.004. Epub 2018 Sep 25. PMID: 30266628; PMCID: PMC6435902.

			Neri M, Villa G, Garzotto F, Bagshaw S, Bellomo R, Cerda J, Ferrari F, Guggia S, Joannidis M, Kellum J, Kim JC, Mehta RL, Ricci Z, Trevisani A, Marafon S, Clark WR, Vincent JL, Ronco C; Nomenclature Standardization Initiative (NSI) alliance. Nomenclature for renal replacement therapy in acute kidney injury: basic principles. Crit Care. 2016 Oct 10;20(1):318. doi: 10.1186/s13054-016-1489-9. PMID: 27719682; PMCID: PMC5056503.

	Continuous Renal Replacement Therapy (CRRT) \| Asahi Kasei Medical Co., Ltd. (n.d.). <nowiki>https://www.asahi-kasei.co.jp/medical/en/apheresis/product/crrt/about/cure.html</nowiki>		Continuous Renal Replacement Therapy (CRRT) \| Asahi Kasei Medical Co., Ltd. (n.d.). <nowiki>https://www.asahi-kasei.co.jp/medical/en/apheresis/product/crrt/about/cure.html</nowiki>

Christopher.Deeble: image

2024-05-04T20:38:13Z

image

← Older revision		Revision as of 13:38, 4 May 2024
Line 24:		Line 24:
	** Clearance of different size of solute similar until the size of the solute reaches with size of the pores		** Clearance of different size of solute similar until the size of the solute reaches with size of the pores
	** Overall CVVH with higher clearance rate than CVVHD for solutes 1,000 to 20,000 Daltons		** Overall CVVH with higher clearance rate than CVVHD for solutes 1,000 to 20,000 Daltons
	[[File:Img 1.png\|thumb\|Figure 1: ~~types~~ of ~~CRRTRecreated~~ based on Tandukar 2019 & Asahi Kasei Medical Co.]]		[[File:Img 1.png\|thumb\|Figure 1: Types of CRRT (Recreated based on Tandukar 2019 & Asahi Kasei Medical Co.)]]
	'''Main types (see figure 1 for diagrams):'''		'''Main types (see figure 1 for diagrams):'''

Christopher.Deeble: added image

2024-05-04T20:37:25Z

added image

← Older revision		Revision as of 13:37, 4 May 2024
Line 24:		Line 24:
	** Clearance of different size of solute similar until the size of the solute reaches with size of the pores		** Clearance of different size of solute similar until the size of the solute reaches with size of the pores
	** Overall CVVH with higher clearance rate than CVVHD for solutes 1,000 to 20,000 Daltons		** Overall CVVH with higher clearance rate than CVVHD for solutes 1,000 to 20,000 Daltons
			[[File:Img 1.png\|thumb\|Figure 1: types of CRRTRecreated based on Tandukar 2019 & Asahi Kasei Medical Co.]]
	'''Main types (see figure 1 for diagrams):'''		'''Main types (see figure 1 for diagrams):'''

Christopher.Deeble: added

2024-05-04T20:31:53Z

added

← Older revision		Revision as of 13:31, 4 May 2024
Line 13:		Line 13:

	== Mechanisms and types ==		== Mechanisms and types ==
	~~Main solute~~ removal mechanisms:		'''Solute removal mechanisms:'''

	* Diffusion		* Diffusion
Line 25:		Line 25:
	** Overall CVVH with higher clearance rate than CVVHD for solutes 1,000 to 20,000 Daltons		** Overall CVVH with higher clearance rate than CVVHD for solutes 1,000 to 20,000 Daltons

			'''Main types (see figure 1 for diagrams):'''
	Main types:

	* SCUF (Slow continuous ultrafiltration)		* SCUF (Slow continuous ultrafiltration)

Christopher.Deeble: added info

2024-05-04T20:27:21Z

added info

@@ Line 11: / Line 11: @@
 Provides renal support to patients. Usually veno-venous, but arterio-venous exists too (not covered here).
 == Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> ==
@@ Line 37: / Line 63: @@
 == References ==
 Cronin B, O'Brien EO. Intraoperative Renal Replacement Therapy: Practical Information for Anesthesiologists. J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2656-2668. doi: 10.1053/j.jvca.2021.10.002. Epub 2021 Oct 8. PMID: 34750060.
 [[Category:Comorbidities]]

Christopher.Deeble at 17:21, 2 May 2024

2024-05-02T17:21:46Z

← Older revision		Revision as of 10:21, 2 May 2024
Line 10:		Line 10:
	}}		}}

	~~Provide a brief summary of this comorbidity~~ here.		Provides renal support to patients. Usually veno-venous, but arterio-venous exists too (not covered here).

	== Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> ==		== Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> ==
Line 35:		Line 35:

	=== Prognosis<!-- Describe the prognosis of this comorbidity --> ===		=== Prognosis<!-- Describe the prognosis of this comorbidity --> ===

	~~== Epidemiology<!-- Describe the epidemiology of this comorbidity --> ==~~

	== References ==		== References ==
			Cronin B, O'Brien EO. Intraoperative Renal Replacement Therapy: Practical Information for Anesthesiologists. J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2656-2668. doi: 10.1053/j.jvca.2021.10.002. Epub 2021 Oct 8. PMID: 34750060.
	[[Category:Comorbidities]]		[[Category:Comorbidities]]

Christopher.Deeble: created page

2024-05-02T16:21:23Z

created page

New page

{{Infobox comorbidity
| other_names =
| anesthetic_relevance =
| specialty =
| signs_symptoms =
| diagnosis =
| treatment =
| image =
| caption =
}}

Provide a brief summary of this comorbidity here.

== Anesthetic implications ==

=== Preoperative optimization ===

=== Intraoperative management ===

=== Postoperative management ===

== Related surgical procedures ==

== Pathophysiology ==

== Signs and symptoms ==

== Diagnosis ==

== Treatment ==

=== Medication ===

=== Surgery ===

=== Prognosis ===

== Epidemiology ==

== References ==

[[Category:Comorbidities]]